RZLT SCHEDULE 13G: SEC filing

Invus Global Management, LLC and affiliated entities

Filed with the SEC on · accession 0002005369-26-000064

RZLT filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 19, 2026. Invus Global Management, LLC and affiliated entities filed a Schedule 13G disclosing beneficial ownership of approximately 6.1% of Rezolute, Inc.'s common stock, including 6,319,631 shares held by Invus Public Equities and 884,625 shares held by Avicenna Life Sci Master Fund. The stock moved -1.2% by the first close after the filing.

Summary of the filing

Invus Global Management, LLC and affiliated entities filed a Schedule 13G disclosing beneficial ownership of approximately 6.1% of Rezolute, Inc.'s common stock, including 6,319,631 shares held by Invus Public Equities and 884,625 shares held by Avicenna Life Sci Master Fund. The filing is a passive investment disclosure under Rule 13d-1(c).

Key details

Shares beneficially owned by Invus Public Equities$6.3M
Shares beneficially owned by Avicenna Fund$885K
Total shares beneficially owned by Raymond Debbane$7.2M
Total shares outstanding of Rezolute, Inc.$118.8M
IssuerRezolute, Inc.
Reporting person, direct holder of 6,319,631 sharesInvus Public Equities, L.P.
General partner of invus public equitiesInvus Public Equities Advisors, LLC
Managing member of invus pe advisorsInvus Global Management, LLC
Managing member of global managementSiren, L.L.C.
Reporting person, direct holder of 884,625 sharesAvicenna Life Sci Master Fund LP
General partner of avicenna fundAvicenna Life Sci Master GP LLC
Managing member of avicenna gpUlys, L.L.C.
President/ceo of various invus entities and reporting personRaymond Debbane

How RZLT stock reacted

Close before

$4.25

Nov 18, 2026

First close after

-1.18%

$4.20

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for RZLT, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for RZLT?

Click here

Frequently asked questions

What did RZLT file with the SEC on Nov 19, 2026?

RZLT filed a SCHEDULE 13G (SEC filing). Invus Global Management, LLC and affiliated entities filed a Schedule 13G disclosing beneficial ownership of approximately 6.1% of Rezolute, Inc.'s common stock, including 6,319,631 shares held by Invus Public Equities and 884,625 shares held by Avicenna Life Sci Master Fund. The filing is a passive investment disclosure under Rule 13d-1(c).

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did RZLT stock react to this filing?

RZLT closed at $4.25 before the filing and $4.20 on Nov 19, 2026 (-1.18%).

Other RZLT SEC filings

Get alerts when RZLT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days